|Analysis of the Drug Delivery Devices Market, Forecast to 2023|
|Adoption of Connected Healthcare Solutions to Improve Patient Adherence and Compliance|
The growing interest in drug delivery devices is more towards micro needle technology for vaccines and hormones. As healthcare companies focus on the transdermal mode of delivery for insulin, companies developing patch technologies have also received huge funding, indicating that the interest in the industry is shifting toward transdermal drug delivery. Great emphasis is being placed on the targeted drug delivery system to help minimize the probability of adverse effects. This system ensures reachability with enhanced efficacy and minimal degradation bypassing the body’s defense mechanisms.
Expanding patient populations and growing unmet medical needs are contributing to a higher demand for healthcare services and leading to increased cost pressures within global healthcare systems. Steadily rising healthcare costs have also led to increased scrutiny on drug pricing by governments, the media, and consumers. In this context, it is understandable that extending the use of generics is considered an important element in most prescribing strategies to achieve substantial savings without impacting patient care. Switching from branded inhaled drugs to lower-cost generics represents an opportunity to reduce the cost of treatments for asthma and chronic obstructive pulmonary disease (COPD).